Analysts' Opinions Are Mixed on These Healthcare Stocks: KalVista Pharmaceuticals (KALV), Roche Holding AG (OtherRHHVF) and Pfizer (PFE)
Melius Research Adjusts Price Target on RTX to $103 From $101
Adobe (ADBE): New Buy Recommendation for This Technology Giant
Bernstein Sticks to Their Hold Rating for Campbell Soup (CPB)
Intl Flavors & Fragrances Analyst Ratings
Adobe Analyst Ratings
Hold Rating on Pfizer: Caution Advised Amid Uncertainties Surrounding Danuglipron
Analysts Offer Insights on Healthcare Companies: Demant (OtherWILLF) and Pfizer (PFE)
Jefferies Sticks to Their Buy Rating for Pfizer (PFE)
BNP Paribas Exane Adjusts Price Target on International Flavors & Fragrances to $112 From $104
Morgan Stanley Adjusts Price Target on Gilead Sciences to $74 From $78
Keefe Bruyette & Woods Adjusts MarketAxess Holdings' Price Target to $222 From $230
Analysts Offer Insights on Healthcare Companies: Illumina (ILMN) and Pfizer (PFE)
MarketAxess Holdings Analyst Ratings
International Flavors & Fragrances (IFF): New Buy Recommendation for This Basic Materials Giant
Altria Group Analyst Ratings
Pfizer Analyst Ratings
Barclays Adjusts Price Target on MarketAxess Holdings to $215 From $225
Barclays Sticks to Its Hold Rating for Gilead Sciences (GILD)
Marketaxess Holdings (MKTX) Gets a Hold From Barclays